Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist under clinical investigation for obesity, but it is not licensed by the MHRA or EMA in the UK
Instead, hold the vial between your palms and roll it gently
Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders
Definitely not getting nauseous like others have described with different brands
Take care
National Center for Biotechnology Information National Institutes of Health Nature Metabolism Cell Metabolism These scientific resources provide valuable literature covering metabolic regulation, NNMT biology, cellular metabolism, obesity research, mitochondrial function, and energy homeostasis